Pharmacokinetic dosage guidelines for elderly subjects

Expert Opinion on Drug Metabolism and Toxicology

Volumn 1, Issue 1, 2005, Pages 33-48

  Turnheim, Klaus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ageing; clearance; dosage guidelines; drug metabolism; elderly; glomerular filtration rate; pharmacokinetics

Indexed keywords

DRUG;

AGING; DOSE RESPONSE; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; PRACTICE GUIDELINE; REVIEW;

AGING; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 33748375756     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.1.1.33     Document Type: Review

References (179)

1. TURNHEIM K: Drug dosage in the elderly: is it rational? Drugs Aging (1998) 13:357-379.
2. MCLEAN AJ, LE COUTEUR DG: Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. (2004) 56:163-184. (Pubitemid 38720828)
3. SEYMOUR KM, ROUTLEDGE PA: Important drug interactions in the elderly. Drugs Aging (1998) 12:485-494.
4. NO AUTHORS LISTED: Do doctors short-change old people? Lancet (1993) 342:1-2 (editorial).
5. MILLER RA: When will the biology of aging become useful? Future landmarks in biomedical gerontology. J. Am. Geriatr. Soc. (1997) 45:1258-1267. (Pubitemid 27430495)
6. SOHAL RS, WEINDRUCH R: Oxidative stress, caloric restriction and aging. Science (1996) 273:59-63. (Pubitemid 26255420)
7. HOLT P: The gastrointestinal tract. In:Handbook of Physiology, Sect. 11: Aging. EJ Masoro (Ed.), Oxford University Press, Oxford, UK (1995):505-554.
8. TURNHEIM K, KRIVANEK P, OBERBAUER R: Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects. Br. J. Clin. Pharmacol. (1999) 48:501-509. (Pubitemid 29454229)
9. GAINSBOROUGH N, MASKREY VL, NELSON ML et al.: The association of age with gastric emptying. Age Ageing (1993) 22:37-40. (Pubitemid 23057346)
10. BALDUCCI L: Anemia, cancer, and aging. Cancer Control (2003) 10:478-486. (Pubitemid 37493952)
11. NORDIN C, NEED AG, MORRIS HA et al.: Effect of age on calcium absorption in postmenopausal women. Am. J. Clin. Nutr. (2004) 80:998-1002. (Pubitemid 41202103)
12. ROSKOS KV, MAIBACH HI: Percutaneous absorption and age. Drugs Aging (1992) 2:432-449.
13. TRAUTINGER F: Mechanisms of photodamage of the skin and its functional consequences for skin ageing. Clin. Exp. Dermatol. (2001) 26:573-577. (Pubitemid 32989581)
14. VESTAL RE: Aging and pharmacology. Cancer (1997) 80:1302-1310. (Pubitemid 27407233)
15. BEAUFRERE B, MORIO B: Fat and protein redistribution with aging: metabolic consi-de-rations. Eur. J. Clin. Nutr. (2000) 54:S48-S53. (Pubitemid 30447300)
16. ROWLAND M, TOZZER TN: Clinical Pharmacokinetics: Concepts and Applications. Williams & Wilkins, Baltimore, MD, USA (1995).
17. CAMPION EW, AVORN J, REDER VA, OLINS NJ: Overmedication of low-weight elderly. Arch. Int. Med. (1987) 147:945-947.
18. GRANDISON MK, BOUDINOT FD: Age-related changes in protein binding of drugs. Clin. Pharmacokinet. (2000) 38:271-290.
19. BENET LZ, HOENER BA: Changes in plasma protein binding have little clinical relevance. Clin. Pharmacol. Ther. (2002) 71:115-121. (Pubitemid 34271114)
20. WOODHOUSE KW, MUTCH E, WILLIAMS FM: Effect of age on pathways of drug metabolism in human liver. Age Ageing (1984) 13:328-334. (Pubitemid 15205672)
21. LE COUTEUR DG, MCLEAN AJ: The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin. Pharmacokinet. (1998) 34:359-373. (Pubitemid 28192906)
22. WALTER-SACK I, KLOTZ U: Influence of diet and nutritional status on drug metabolism. Clin. Pharmacokinet. (1996) 31:47-64. (Pubitemid 26238202)
23. BRENNER SS, KLOTZ U: P-glycoprotein function in the elderly. Eur. J. Clin. Pharmacol. (1991) 60:97-102.
24. BRICKER NS, MORRIN PA, KIME SW: The pathologic physiology of chronic Bright's disease. An exposition of the 'intact nephron hypothesis'. Am. J. Medicine (1960) 28:77-98.
25. DETTLI L: Individualization in drug dosage in patients with renal disease. Med. Clin. North Am. (1974) 58:977-985.
26. SPRING P: Calculation of drug dosage regimens in patients with renal disease: a new nomographic method. Int. J. Clin. Pharmacol. Biopharm. (1975) 11:76-90.
27. FEHRMAN-EKHOLM I, SKEPPHOLM L: Renal function in the elderly (70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand. J. Urol. Nephrol. (2004) 38:73-77. (Pubitemid 38241426)
28. COCKROFT DW, GAULT MH: Prediction of creatinine clearance from serum creatinine. Nephron (1976) 16:31-41.
29. WRIGHT JG, BODDY AV, HIGHLEY M et al.: Estimation of glomerular filtration rate in cancer patients. Br. J. Cancer (2001) 84:452-459. (Pubitemid 32215868)
30. FLISER D, BISCHOFF I, HANSES A et al.: Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged. Eur. J. Clin. Pharmacol. (1999) 55:205-211. (Pubitemid 29244648)
31. LEVEY AS, BOSCH JP, LEWIS JB et al.: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann. Intern. Med. (1999) 130:461-470. (Pubitemid 29135798)
32. GUTSTEIN HB, AKIL H: Opioid analgesics: In:Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th Ed. JG Hardman, LE Limbird, AG Gilman (Eds), McGraw-Hill, New York, USA (2001):569-619.
33. TURNHEIM K: When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp. Gerontology (2003) 38:843-853. (Pubitemid 36952666)
34. GURWITZ JH: The ambiguous relation between aging and adverse drug reactions. Ann. Int. Med. (1991) 114:956-966.
35. BEARD K: Are drugs really toxic for older people? Expert Opin. Drug Saf. (2003) 2:211-213.
36. BEERS MH, OUSLANDER JG, ROLLINGER J et al.: Explicit criteria for determining inappropriate medication use in nursing homes. Arch. Intern. Med. (1991) 151:1825-1832.
37. BEERS MH: Explicit criteria for determining potentially inappropriate medication use in the elderly. An update. Arch. Int. Med. (1997) 157:1531-1536. (Pubitemid 27305197)
38. FICK DM, COOPER JW, WADE WE et al.: Updating the Beers criteria for potentially inappropriate medication in older adults. Results of a US consensus panel of experts. Arch. Intern. Med. (2003) 163:2716-2724. (Pubitemid 37517412)
39. GOULDING MR: Inappropriate medication prescribing for elderly ambulatory care patients. Arch. Intern. Med. (2004) 164:305-312. (Pubitemid 38176470)
40. LIU GG, CHRISTENSEN DB: The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J. Am. Pharm. Assoc. (2002) 42:847-857.
41. TURNHEIM K: Drug therapy in the elderly. Exp. Gerontol. (2004) 39:1731-1738. (Pubitemid 39576143)
42. BODNAR AG, OELLETTE M, FROLKIS M et al.: Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 279:349-352. (Pubitemid 28063364)
43. FICHTL B: Pharmakokinetische Daten. In:Allgemeine und spezielle Pharmakologie u nd Toxikologie, 9th Ed. K Aktories, U F'rstermann, F Hofmann, K Starke (Eds), Urban & Fischer, M'nchen, Germany (2005):98-113.
44. DIVOLL M, ABERNETHY MA, AMEER B et al.: Acetaminophen kinetics in the elderly. Clin. Pharmacol. Ther. (1982) 31:151-156. (Pubitemid 12149380)
45. LEMMENS HJM, BURN AGL, HENNIS PJ et al.: Influence of age on the pharmacokinetics of alfentanil: gender dependence. Clin. Pharmacokinet. (1990) 19:416-422.
46. MÜHLBERG W, RIECK W, ARNOLD E et al.: Pharmacokinetics of alprazolam in elderly patients with multiple diseases. Arch. Gerontol. Geriatr. (1997) 25:91-100. (Pubitemid 27213998)
47. KAPLAN GB, GREENBLATT DJ, EHRENBERG BL et al.: Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects. J. Clin. Pharmacol. (1998) 38:14-21. (Pubitemid 28086717)
48. VAN HAEVENBECK M, SISKA G, HERCHUELZ A: Pharmacokinetics of once-daily amikacin in elderly patients. J. Antimicrob. Chemother. (1993) 31:185-187. (Pubitemid 23078088)
49. SOMOGYI A, HEWSON D, MUIRHEAD M et al.: Amiloride disposition in geriatric patients: importance of renal function. Br. J. Clin. Pharmacol. (1990) 29:1-8. (Pubitemid 20130545)
50. VADIEI K, TROY S, KORTHBRADLEY J et al.: Population kinetics of intravenous amiodarone and comparison with two stage pharmacokinetic analysis. J. Clin. Pharma-col. (1997) 37:610-617. (Pubitemid 27443542)
51. SCHULZ P, TURNER-TAMIYASU K, SMITH G et al.: Amitriptylin disposition in young and elderly normal men. Clin. Pharmacol. Ther. (1983) 33:360-366. (Pubitemid 13089528)
52. ABERNETHY DR, GUTKOWSKA J, WINTERBOTTOM LM: Effects of amlodipine: a long-acting dihydropyridine calcium antagonist, in aging hypertension: pharmacodynamics in relation to disposition. Clin. Pharmacol. Ther. (1990) 48:76-86. (Pubitemid 20236205)
53. MEYERS BR, WILKINSON P: Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage. Clin. Pharmacokinet. (1989) 17:385-395. (Pubitemid 20020152)
54. CHAMPOUX N, DU SOUICH P, RAVAOARINORO M et al.: Single-dose pharmacokinetics of ampicilline and tobramycin administered by hypodermoclysis in young and older healthy volunteers. Br. J. Clin. Pharmacol. (1996) 42:325-331. (Pubitemid 26284421)
55. OERTEL R, EBERT U, RAHN R, KIRCH W: The effect of age on pharmacokinetics of the local anesthetic drug articaine. Reg. Anesth. Pain Med. (1999) 24:524-528.
56. SOWINSKI KM, FORREST A, WILTON JH et al.: Effect of aging on atenolol pharmacokinetics and pharmacodynamics. J. Clin. Pharmacol. (1995) 35:807-814.
57. ORNSTEIN E, LIEN CA, MATTEU RS et al.: Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Anesthesiology (1996) 84:520-525. (Pubitemid 26093706)
58. MÜHLBERG W; MUTSCHLER E, HOFNER A et al.: The influence of age on the pharmacokinetics and pharmacodynamics of bemetizide and triamterene: a single and multiple dose study. Arch. Gerontol. Geriatr. (2001) 32:265-273. (Pubitemid 32505691)
59. KAISER G, ACKERMANN R, DIETERLE W et al.: Pharmacokinetics and pharmaco-dynamics of the ACE inhibitor benazepril in the elderly. Eur. J. Clin. Pharmacol. (1990) 38:379-385. (Pubitemid 20144393)
60. OCHS HR, GREENBLATT DJ, FRIEDMAN H et al.: Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propralolol. Clin. Phar-macol. Ther. (1987) 41:562-570. (Pubitemid 17074333)
61. OBERBAUER R, KIVANEK P, TURNHEIM K: Pharmacokinetics and pharmacodynamics of the diuretic bumetanide in the elderly. Clin. Pharmacol. Ther. (1995) 57:42-51.
62. VEERING BT, BURM AG, VLETTER AA et al.: The effect of age on the systemic absorption, disposition and pharmacodynamics of bupivacain after epidural administration. Clin. Pharmacokinet. (1992) 22:75-84.
63. SWEET RA, POLLOCK BG, KIRSHNER M et al.: Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression. J. Clin. Pharmacol. (1995) 35:876-884.
64. BERNUS I, DICKINSON RG, HOOPER WD et al.: Anticonvulsant therapy in aged patients: clinical pharmacokinetic implications. Drugs Aging (1997) 10:287-289.
65. BARBHAIJA RH, KNUPP CA, PITTMAN KA: Effects of age and gender on pharmacokinetics of cefepim. Antimicrob. Agents Chemother. (1992) 36:1181-1185.
66. GREENBLATT DJ, DIVOLL MK, ABERNETHY DR et al.: Age and gender effects of chlordiazepoxide kinetics: relation to antipyrine disposition. Pharmacology (1989) 38:327-334. (Pubitemid 19170892)
67. NILSSON-EHLE I, LJUNBERG B: Quinolone disposition in the elderly: practical implications. Drugs Aging (1991) 1:279-288.
68. MINAMI H, OHE Y, NIHO S et al.: Comparison of pharmacokinetics and pharmacodynamics of docetaxel and cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients? J. Clin. Oncol. (2004) 22:2901-2908. (Pubitemid 41079910)
69. GUTIERREZ M, ABRAMOWITZ W: Steady-state pharmacokinetics of citalopram in young and elderly subjects. Pharmacotherapy (2000) 20:1441-1447.
70. CHU SY, WILSON DS, GUAY DR et al.: Clarithromycin pharmacokinetics in healthy young and elderly volunteers. J. Clin. Pharmacol. (1992) 32:1045-1049.
71. DIVOLL M, GREENBLATT DJ, ABERNETHY DR et al.: Cimetidine impairs clearance of antipyrine and desmethyldiazepam in the elderly. J. Am. Geriatr. Soc. (1982) 30:684-689. (Pubitemid 13198444)
72. DEES EC, O'REILLY S, GOODMAN SN et al.: A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest. (2000) 18:521-529. (Pubitemid 30485668)
73. KOVARIK JM, KOELLE EU: Cyclosporine pharmacokinetics in the elderly. Drugs Aging. (1999) 15:197-205.
74. DVORCHIK B, DAMPHOUSSE D: Single-dose pharmacokinetics of daptomycin in young and geriatric volunteers. Int. J. Clin. Pharmcol. (2004) 44:612-620. (Pubitemid 38668024)
75. DIVOLL M, GREENBLATT DJ, OCHS HR et al.: Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth. Analg. (1983) 62:1-8. (Pubitemid 13193092)
76. HERMAN RJ, WILKINSON GR: Disposition of diazepam in young and elderly subjects after acute and chronic dosing. Br. J. Clin. Pharmacol. (1996) 42:147-155. (Pubitemid 26255059)
77. CUSACK B, KELLY JG, O'MALLY K: The cardiac glycosides. In:Clinical Pharmacology in the Elderly. CG Swift (Ed.), Marcel Dekker, New York, USA (1987):149-177.
78. SIMMONS KJ, WATSON TA, MARTIN TJ et al.: Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults and children. J. Clin. Phar-macol. (1990) 30:665-671. (Pubitemid 20241475)
79. DEMPSEY E, BOURQUE S, SPENARD J, LANDRIAULT H: Pharmacokinetics of single intravenous and oral doses of dolasetron mesylate in healthy elderly volunteers. J. Clin. Pharmacol. (1996) 36:903-910. (Pubitemid 26384480)
80. DRESNER DL, BASTA SJ, ALI HH et al.: Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia. Anesth. Analg. (1990) 71:498-502. (Pubitemid 20380598)
81. SILVERBERG PA, MATTEO RS, ORNSTEIN E et al.: Pharmacokinetics and pharmacodynamics of edrophonium in the elderly (Abstract). Anesth. Analg. (1986) 6:S142.
82. NIX DE, MAJUMDAR AK, DINUBILE MJ: Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. J. Antimicrob. Chemother. (2004) 53(Suppl. 2):ii23-ii28.
83. MIGLIOLI PA, PIVETTA P, STRAZZABSCO M et al.: Effect of age on single- and multiple dose pharmacokinetics of erythromycin. Eur. J. Clin. Pharmacol. (1990) 39:161-164. (Pubitemid 20249990)
84. PFLÜGER KH, HAHN M, HOLZ JB et al.: Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions. Cancer Chemother. Pharmacol. (1993) 31:350-356. (Pubitemid 23045646)
85. ECHIZEN H, ISHIZAKI T: Clinical pharmacokinetics of famotidine. Clin. Pharmacokinet. (1991) 21:178-194.
86. RICHENS A, BANFIELD CR, SALFI M et al.: Single and multiple dose pharmacokinetics of felbamate in the elderly. Br. J. Clin. Pharmacol. (1997) 44:129-134. (Pubitemid 27327063)
87. BLYCHERT E, EDGAR B, ELMFELDT D, HEDNER T: A population study of the pharmacokinetics of felodipine. Br. J. Clin. Pharmacol. (1991) 31:15-24.
88. SINGELTON MA, ROSEN JI, FISHER DM: Pharmacokinetics of fentanyl in the elderly. Br. J. Anaesth. (1988) 60:619-622.
89. TABURET AM, DEVILLER A, THOMARE P et al.: Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients. Clin. Pharmacokinet. (1990) 19:80-88. (Pubitemid 20204826)
90. GATH J, CHARLES B, SAMPSON J et al.: Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients. J. Clin. Pharmacol. (1995) 35:31-36.
91. RONCARI G, TIMM U, ZELL M et al.: Flumazenil kinetics in the elderly. Eur. J. Clin. Pharmacol. (1993) 45:585-587. (Pubitemid 24036941)
92. PORT RE, DANIEL B, DING RW et al.: Relative importance of dose, body surface area, sex, and age for 5-fluorouracil clearance. Oncology (1991) 48:277-281.
93. PATEL BK, JACKSON SHD, SWIFT CG, HUTT AJ: Disposition of flurbiprofen in man: influence of stereochemistry and age. Xenobiotica (2003) 33:1043-1057. (Pubitemid 37346686)
94. ANDREASEN F, HANSEN N, HUSTED SE, JANSEN JA: The pharmacokinetics of furosemide are influenced by age. Br. J. Clin. Pharmacol. (1983) 16:391-397. (Pubitemid 13015763)
95. BOYD RA, TURCK D, ABEL RB et al.: Effects of age and gender on single-dose pharmacokinetics of gabapentin. Epilepsia (1999) 40:474-479. (Pubitemid 29164860)
96. EL-SAYED YM, ISLAM SI: Effect of age and renal function on gentamicin pharmacokinetic parameters. Int. J. Clin. Pharmacol. (1989) 27:503-509. (Pubitemid 19246549)
97. JABER LA, ANTAL EF, WELSHMAN IR: Pharmacokinetics and pharmacodynamics of glyburide in young and elderly patients with non-insulin-dependent diabetes mellitus. Ann. Pharmacother. (1996) 30:472-475. (Pubitemid 26139241)
98. ALBERT KS, GILLESPIE WR, WAGNER JG et al.: Effects of age on the clinical pharmacokinetics of ibuprofen. Am. J. Med. (1984) 77:47-50. (Pubitemid 14050197)
99. LEONI F, CIOLLI S, GIULIANI G et al.: Attenuated-dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results. Br. J. Haematol. (1995) 90:169-174.
100. ABERNETHY DR, GREENBLATT DJ, SHADER RI: Imipramine and desipramine disposition in the elderly. J. Pharmacol. Exp. Ther. (1985) 232:183-188. (Pubitemid 15193670)
101. CSAJKA C, MARZOLINI C, FATTINGER K et al.: Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. (2004) 48:3226-3232. (Pubitemid 39129311)
102. OBERBAUER R, KRIVANEK P; TURNHEIM K: Pharmacokinetics of indomethacin in the elderly. Clin. Pharmacokinet. (1993) 24:428-434. (Pubitemid 23135689)
103. ADVENIER C, SAINT-AUBIN A, GOBERT C et al.: Pharmacokinetics of isoniazid in the elderly. Br. J. Clin. Pharmacol. (1980) 10:167-168. (Pubitemid 10090741)
104. KELLY JG, MCGARRY K, O'MALLEY K, O'BRIAN ET: Bioavailability of labetalol increases with age. Br. J. Clin. Pharmacol. (1982) 14: 304-305. (Pubitemid 13141898)
105. CHAN V, MORRIS RG, ILET KG et al.: Population pharmacokinetics of lamotrigine. Ther. Drug Monit. (2001) 23:630-635. (Pubitemid 33086490)
106. HUSSEIN Z, GRANNEMAN GR, MUKHERJEE D et al.: Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole. Br. J. Clin. Pharmacol. (1993) 36:391-398. (Pubitemid 23344147)
107. PATSALOS PM: Clinical pharmacokinetics of levetirazetam. Clin. Pharmacokinet. (2004) 43:707-724.
108. SIMON MJ, VEERING BT, STIESTRA R et al.: Effect of age on the clinical profile and systemic absorption and disposition of levobupivacaine after epidural administration. Br. J Anaesth. (2004) 93:512-520. (Pubitemid 39359880)
109. ROBERTSON DRC, WOOD ND, EVEREST H et al.: The effect of age on the pharma-cokinetics of levodopa administered alone and in the presence of carbidopa. Br. J. Clin. Pharmacol. (1989) 28:61-69. (Pubitemid 19195666)
110. CHIEN SC, CHOW AT, NATARAJAN J et al.: Absence of age and gender effects on the pharmacokinetics of a single 500 mg oral dose of levofloxacin in healthy subjects. Antimicrob. Agents Chemother. (1997) 41:1562-1565. (Pubitemid 27289687)
111. ABERNETHY DR, GREENBLATT DJ: Impairment of lidocain clearance in elderly male subjects. J. Cardiovasc. Pharmacol. (1983) 5:1093-1096. (Pubitemid 14240327)
112. SISSON TL, JINGBLUTH GL, HOPKINS NK: Age and sex effects on the pharmacokinetics of linezolid. Eur. J. Clin. Pharmacol. (2002) 57:793-797. (Pubitemid 34143337)
113. GREENBLATT DJ, DIVOLL AM, LOCNISKAR A et al.: Lorazepam kinetics in the elderly. Clin. Pharmacol. Ther. (1979) 26:103-113. (Pubitemid 10211195)
114. SAMBOL NC, CHIANG J, LIN ET et al.: Kidney function and age are both predictors of pharmacokinetics of metformin. J. Clin. Pharmacol. (1995) 35:1094-1102.
115. BRESSOLLE F, BOLOGNA C, KINOWSKI JM et al.: Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis: a comparison with young patients. J. Rheumatol. (1997) 24:1903-1909. (Pubitemid 27431920)
116. TORNATORE KM, LOGUE G, VENUTO RC, DAVIS PJ: Pharmacokinetics of methylprednisolone in young and elderly males. J. Am. Geriatr. Soc. (1994) 42:1118-1122. (Pubitemid 24309825)
117. WYNNE HA, YELLAND C, COPE LH et al.: The association of age and frailty with the pharmacokinetics and pharmacodynamics of metoclopramide. Age Ageing (1993) 22:354-359. (Pubitemid 23282362)
118. MATTEO RS, BACKUS WW, MCDANIEL DD et al.: Pharmacokinetics and pharmaco-dynamics of D-tubocurarine and metocurine in the elderly. Anesth. Analg. (1985) 64:23-29. (Pubitemid 15178836)
119. TAGUCHI N, NOZAWA T, MIZUMAKI K et al.: Nonlinear mixed effects model analysis of the pharmacokinetic of metoprolol in routinely treated Japanese patients. Biol. Pharm. Bull. (2004) 27:1642-1648. (Pubitemid 41701655)
120. LAU AH, LAM NP, PISCITELLI SC et al.: Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives. Clin. Pharmacokinet. (1992) 23:328-364.
121. MEYERS BR, MENDELSON MH, SRULEVICH-CHIN E et al.: Pharmacokinetic properties of mezlocillin in ambulatory elderly subjects. J. Clin. Pharmacol. (1987) 27:678-681. (Pubitemid 18048608)
122. SERVIN F, ERIQUEZ I, FOURNET M et al.: Pharmacokinetics of midazolam used as an intravenous induction agent for patients over 80 years of age. Eur. J. Anaesthesiol. (1987) 4:1-7. (Pubitemid 17216263)
123. ALBRECHT S, IHMSEN H, HERING W et al.: The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin. Pharmacol. Ther. (1999) 65:630-639. (Pubitemid 29294026)
124. STOECKEL K, PFEFEN JP, MAYERSON M et al.: Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney function. Acta Psychiatr. Scand. (1990) 360:94-97. (Pubitemid 20320310)
125. ZHAO JJ, ROGERS D, HOLLAND SD et al.: Pharmacokinetic and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers. Biopharm. Drug Dispos. (1997) 18:769-777. (Pubitemid 27517566)
126. STANSKI DR, GREENBLATT DJ, LOWENSTEIN E: Kinetics of intravenous and intramuscular morphine. Clin. Pharmacokinet. (1978) 24:52-59. (Pubitemid 8407211)
127. WISE R: A review of the clinical pharmacology of moxifloxacin, a new 8-methoxy-quino-lone, and its potential relation to therapeutic efficacy. Clin. Drug Invest. (1999) 17:365-387. (Pubitemid 29253469)
128. SULLIVAN JT, LETTIERI JT, LIU P, HELLER AH: The influence of age and gender on the pharmacokinetics of moxifloxacin. Clin. Pharmacokinet. (2001) 40(Suppl. 1):11-18. (Pubitemid 32295677)
129. HULOT T, GAMAND S, DUPAIN T et al.: Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers. Arzneimittelforschung (Drug Research) (1998) 48:900-904. (Pubitemid 28427405)
130. FRYE RF, MATZKE GR, JALLAD NS et al.: The effect of age on the pharmacokinetics of the opioid antagonist nalmefene. Br. J Clin. Pharmacol. (1996) 42:301-306. (Pubitemid 26284417)
131. UPTON RA, WILLIAMS RL, KELLY J, LONES RM: Naproxen pharmacokinetics in the elderly. Br. J. Pharmacol. (1984) 18:207-214. (Pubitemid 14054871)
132. BARBHAIJA RH, BUCH AB, GREENE DS: A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses. J. Clin. Psychopharmacol. (1996) 16:19-25. (Pubitemid 26060752)
133. FRYDMAN A: Pharmacokinetic profile of nicorandil in humans: an overview. J. Cardiovasc. Pharmacol. (1992) 20(Suppl. 3):S34-S44.
134. ROBERTSON DRC, WALLER DG, RENWICK AG et al.: Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br. J. Clin. Pharmacol. (1988) 25:297-305.
135. MUCK W, BREUEL HP, KUHLMANN J: The influence of age on the pharmacokinetics of nimodipine. Int. J. Clin. Pharmacol. Ther. (1996) 34:293-298. (Pubitemid 26235416)
136. GREENBLATT DJ, ABERNETHY DR, LOCNISKAR A et al.: Age, sex, and nitrazepam kinetics: relation to antipyrine disposition. Clin. Pharmacol. Ther. (1985) 38:697-703. (Pubitemid 16124385)
137. PHYSICIANS DESK REFERENCE 2002: Prilosec® (Omeprazole), Medical Economics Comp., Montvale, NJ, USA (2002):628.
138. PRITCHARD JF, BRYSON JC, KERNODLE AE et al.: Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers. Clin. Pharmacol. Ther. (1992) 51:51-55.
139. VAN HEININGEN PN, EVE MD, OOSTERHUIS B et al.: The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine. Clin. Pharmacol. Ther. (1991) 50:410-419.
140. NAKAMURA Y, SEKINE I, FURUSE K et al.: Retrospective comparison of toxicity and efficacy in Phase II trials of 3-h infusions of paclitaxel for patients 70 years of age or older and patients under 70 years of age. Cancer Chemother. Pharmacol. (2000) 46:114-118. (Pubitemid 30624843)
141. LEES KR, GREEN ST, REID JL: Influence of age on the pharmacokinetics and pharmacodynamics of perindopril. Clin. Pharmacol. Ther. (1988) 44:418-425. (Pubitemid 18259852)
142. RICHARDSON CJ, BLOCKA KLN, ROSS SG, VERBEEK RK: Effects of age and sex on piroxicam disposition. Clin. Pharmacol. Ther. (1985) 37:13-18. (Pubitemid 16225160)
143. ANDROS E, DETMAR-HANNA D, SUTEPARUK S et al.: The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur. J. Clin. Pharmacol. (1996) 50:41-46. (Pubitemid 26140090)
144. MARTINES C, GATTI G, SASSO E et al.: The disposition of primidone in elderly patients. Br. J. Clin. Pharmacol. (1990) 30:607-611. (Pubitemid 20346488)
145. SCHÜTTLER J, IHMSEN H: Population pharmacokinetics of propofol. A multicenter study. Anesthesiology (2000) 92:727-738. (Pubitemid 30130176)
146. CASTLEDEN CM, GEORGE CF: the effect of ageing on the hepatic clearance of propranolol. Br. J. Clin. Pharmacol. (1979) 7:49-54. (Pubitemid 9096745)
147. PANTON LB, GUILLEN GJ, WILLIAMS L et al.: The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults. J. Clin. Pharmacol. (1995) 35:885-894.
148. DE VANE CL, NEMEROFF CB: Clinical pharmacokinetics of quetiapine. Clin. Pharmacokinet. (2002) 40:509-522.
149. OCHS HR, GREENBLATT DJ, WOO E, SMITH TW: Reduced quinidine clearance in elderly persons. Am. J. Cardiol. (1978) 42:481-485. (Pubitemid 9022080)
150. AMMON S, TREIBER G, KEES F, KLOTZ U: Influence of age on the steadystate disposition of drugs commonly used for the eradication of Helicobacter pylori. Aliment. Pharmacol. Ther. (2000) 14:759-766. (Pubitemid 30352743)
151. SNOECK E, VAN PEER A, SACK M et al.: Influence of age, renal and liver impair-ment on the pharmacokinetics of risperidone in man. Psychopharmacology (1995) 122:223-229.
152. MUSSON DG, BIRK DL, PANEBIANCO KD et al.: Pharmacokinetics of rizatriptan in healthy elderly subjects. Int. J. Clin. Pharmacol. Ther. (2001) 39:447-452. (Pubitemid 32923172)
153. GREENBLATT DJ, ABERNETHY DR, BOXENBAUM HG et al.: Influence of age, gender, and obesity on salicylate kinetics following single doses of aspirin. Arch. Rheum. (1986) 29:971-980. (Pubitemid 16049256)
154. WONG SL, CAO GL, MACK RL, GRANNEMANN GR: Pharmacokinetics of sertindole in healthy young and elderly male and female subjects. Clin. Pharmacol. Ther. (1997) 62:157-164. (Pubitemid 27373463)
155. RONFIELD RA, TREMAINE LM, WILDNER KD: Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin. Pharmacokinet. (1992) 32(Suppl. 1):22-30. (Pubitemid 27107716)
156. HIND ID, MANGHAM JE, GHANI SP et al.: Sibutramine pharmacokinetics in young and elderly healthy subjects. Eur. J. Clin. Pharmacol. (1999) 54:847-849. (Pubitemid 29051330)
157. MUIRHEAD GJ, WILNER K, COLBURN W et al.: The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil. Br. J. Clin. Pharmacol. (2002) 53(Suppl. 1):21S-30S.
158. HELMERS JH, VAN LEEUWEN L, ZUURMOND WW: Sufentanil pharmacokinetics in young adults and elderly surgical patients. Eur. J. Anaesthesiol. (1994) 11:181-185. (Pubitemid 24140704)
159. TAGGART AJ, MCDERMOTT BJ, ROBERTS SD: The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis. Clin. Pharmacokinet. (1992) 23:311-320.
160. ROWLAND M: Clinical pharmacokinetics of teicoplanin. Clin. Pharmacokinet. (1990) 18:184-209. (Pubitemid 20109453)
161. STANGIER J, SU CA, ROTH W: Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients. J. Int. Med. Res. (2000) 28:149-167. (Pubitemid 30648951)
162. SITAR DS, WARREN CP, AOKI FY: Pharmacokinetics and pharmacodynamics of bambuterol, a long-acting bronchodilator prodrug of terbutaline, in young and elderly patients with asthma. Clin. Pharmacol. Ther. (1992) 52:297-306.
163. EDWARDS DY, ZAROWITZ BJ, SLAUGHTER RL: Theophylline. In:Applied Pharmacokinetics, 3rd Ed. WE Evans, JJ Schentag, WJ Jusko (Eds), Applied Therapeutics, Inc., Vancouver, WA, USA (1992):13.1-13.38.
164. SNELL S, JANSEN JA, MENGEL HB et al.: The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy. J. Clin. Pharmacol. (1997) 37:1015-1020. (Pubitemid 27524561)
165. SHAH J, TEITELBAUM P, MOLONY B et al.: Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects. Br. J. Clin. Pharmacol. (1991) 32:761-764.
166. CHEER SM, DUNN CJ, FOSTER R: Tinzaparin sodium. A review of its pharmacology and clinical use in the prophylaxis and treatment of thromboembolic disease. Drugs (2004) 64:1479-1502. (Pubitemid 38980459)
167. FRUNCILLO R, TROY S, PARKER V et al.: Pharmacokinetics of the aldose reductase inhibitor tolrestat: studies in healthy young and elderly male and female subjects and subjects with diabetes. Clin. Pharmacol. Ther. (1996) 59:603-612. (Pubitemid 26233416)
168. BORKOWSKI JM, DUERR M, DONEHOWER RC et al.: Relation between age and clearance rate of nine investigational anticancer drugs from Phase I pharmacokinetic data. Cancer Chemother. Pharmacol. (1994) 33:493-496. (Pubitemid 24082344)
169. GREENBLATT DJ, FRIEDMAN H, BURSTEIN ES et al.: Trazodone kinetics: effect of age, gender, and obesity. Clin. Pharmacol. Ther. (1987) 42:193-200. (Pubitemid 17135976)
170. GREENBLATT DJ, HARMATZ JS, VON MOLTKE LL et al.: Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate. Clin. Pharmacol. Ther. (2004) 76:467-479. (Pubitemid 39469870)
171. VAROQUAUX O, LAJOIE D, GOBERT C et al.: Pharmacokinetics of trimethoprim-sulfamethoxazole combination in the elderly. Br. J. Clin. Pharmacol. (1985) 20:575-581.
172. FELIX S, SPROULE BA, HARDY BG et al.: Dose-related pharmacokinetics and pharmacodynamics of valproate in the elderly. J. Clin. Psychopharmacol. (2003) 23:471-478. (Pubitemid 37128675)
173. SIOUFI A, JAOUEN A, CARDOT JM et al.: The effects of age on the pharmacokinetics of valsartan. Biopharm. Drug Dispos. (1998) 19:237-244.
174. GUAY DR, VANCE-BRYAN K, GILLILAND S et al.: Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster. J. Clin. Pharmacol. (1993) 33:918-922. (Pubitemid 23304642)
175. ABERNETHY DR, SCHWARTZ JB, TODD EL et al.: Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Ann. Intern. Med. (1986) 105:329-336.
176. JOHANSSON LC, FRISON L, LOGREN U et al.: Influence of age on the pharmaco-kinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor. Clin. Pharmacokinet. (2003) 42:381-392. (Pubitemid 36433878)
177. BRAEKMAN RA, GRANNEMAN GR, LOCKE CS et al.: The pharmacokinetics of zileuton in healthy young and elderly volunteers. Clin. Pharmacokinet. (1995) 29(Suppl. 2):42-48.
178. PECK RW, SEABER EJ, DIXON RM et al.: The pharmacodynamics and pharmacokinetics of the 5HT1B/1Dagonist zolmitriptan in healthy young and elderly men and women. Clin. Pharmacol. Ther. (1998) 63:342-353. (Pubitemid 28182232)
179. OLUBODUN JO, OCHS HR, VON MOLTKE LL et al.: Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men. Br. J. Clin. Pharmacol. (2003) 56:297-304. (Pubitemid 37069221)